Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 4/20 | 0.41 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.34 |
| ▸ | KRAS | P01116 | 1/20 | 0.33 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | ACACA | Q13085 | 1/20 | 0.32 |
| ▸ | FPR3 | P25089 | 2/20 | 0.31 |
| ▸ | FPR2 | P25090 | 2/20 | 0.31 |
| ▸ | ATRIP | Q8WXE1 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 3/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
| ▸ | MIF | P14174 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869057 | 0.86 | ATR (0.44) | ATRKRASACACBACACAFPR3 | |
| SCHEMBL32690882 | 0.86 | RXRA (0.33) | RXRARXRBRXRG | |
| SCHEMBL30797747 | 0.84 | ATR (0.41) | ATRPRMT5WDR77USP30KRAS | |
| SCHEMBL30797881 | 0.84 | ATR (0.47) | ATRPRMT5WDR77USP30KRAS | |
| SCHEMBL30869128 | 0.84 | ATR (0.43) | ATRKRASACACBACACAFPR3 | |
| SCHEMBL27376667 | 0.84 | ATR (0.41) | ATRPRMT5WDR77USP30KRAS | |
| SCHEMBL30869105 | 0.82 | ATR (0.43) | ATRKRASACACBACACAFPR3 | |
| SCHEMBL30869056 | 0.82 | ATR (0.44) | ATRKRASACACBACACAATRIP | |
| SCHEMBL30869132 | 0.76 | ATR (0.44) | ATRPRMT5WDR77USP30FPR3 | |
| SCHEMBL30869075 | 0.76 | ATR (0.40) | ATRPRMT5WDR77USP30ATRIP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584249-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052702-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |